obafluorin: from Pseudomonas fluorescens; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 146354 |
| SCHEMBL ID | 2277925 |
| MeSH ID | M0125595 |
| Synonym |
|---|
| obafluorin |
| 2,3-dihydroxy-n-[(2r,3s)-2-[(4-nitrophenyl)methyl]-4-oxooxetan-3-yl]benzamide |
| benzamide, 2,3-dihydroxy-n-(2-((4-nitrophenyl)methyl)-4-oxo-3-oxetanyl)-, cis- |
| 92121-68-1 |
| SCHEMBL2277925 |
| DTXSID90238870 |
| 2,3-dihydroxy-n-[(2r,3s)-2-[(4-nitrophenyl)methyl]-4-oxo-3-oxetanyl]-benzamide |
| 2,3-dihydroxy-n-((2r,3s)-2-(4-nitrobenzyl)-4-oxooxetan-3-yl)benzamide |
| HY-138075 |
| CS-0144459 |
| AKOS040756182 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (24.17) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||